Maryland’s Crackdown On Drug Price Gouging Riles Up Big Pharma
The law applies to generic or off-patent drug makers that manufacture a medicine at least three other firms also make.
BALTIMORE — A trade group for generic drugmakers brought a federal complaint Thursday to block Maryland’s attempt of a crackdown on pharmaceutical price gouging.